Last updated: February 21, 2026
What Is the Scope of Patent AU2009282474?
Patent AU2009282474 is a patent filed in Australia that relates to a pharmaceutical invention. Its scope appears to focus on specific formulations or methods related to a given drug candidate. Based on available patent documents, the invention pertains to a novel composition, method of manufacture, or use that offers specific therapeutic or stability advantages over prior art.
The patent's scope covers:
- Drug compositions: Particular combinations of active ingredients with specific excipients or carriers.
- Method of preparation: Techniques to synthesize, formulate, or process the pharmaceutical compound.
- Therapeutic methods: Use of the composition for treating specific diseases or conditions, as claimed.
The scope is limited geographically to Australia but may have counterparts or priority claims in other jurisdictions.
What Are the Key Claims?
The claims of AU2009282474 define the exclusive rights conferred by the patent, often including multiple dependent claims. A summary of core claims:
-
Independent Claims: Typically describe the essential invention, such as a pharmaceutical composition comprising a specified active ingredient in a defined concentration range, combined with particular excipients, or a method of treating a disease with the composition.
-
Dependent Claims: Narrower claims specify particular formulations, dosages, or manufacturing conditions.
Example Claim Structure (Hypothetical)
-
Claim 1: A pharmaceutical composition comprising [active compound] in an amount effective to treat [disease], combined with [excipients].
-
Claim 2: The composition of claim 1, wherein the active compound is present in a concentration of X%.
-
Claim 3: A method of manufacturing the composition as claimed in claim 1, involving [specific process conditions].
-
Claim 4: Use of the composition as claimed for treating [specific medical condition].
Exact claim language details are necessary for precise legal scope but generally follow this pattern.
Patent Landscape Analysis
Patent Families and Related Patents
-
Family members: Patents filed in other jurisdictions, such as US, Europe, and China, often linked to the Australian patent through priority filings.
-
Related patents: Cover similar compounds or formulations, creating a landscape of overlapping rights.
Competitor Patents
- Major pharmaceutical companies or biotech firms likely hold competing patents for related compounds or delivery methods.
Overlap with Existing Art
-
The patent references prior art patents and publications, particularly those covering similar compounds or therapeutic methods.
-
The novelty depends on the differences from prior art, which may involve unique formulation features or use indications.
Patent Term and Maintenance
-
The patent's initial term lasts 20 years from the earliest priority date (likely around 2009 based on serial number), subject to maintenance fees.
-
Continuous claims and filings could extend or modify scope.
Patent Challenges
Implications for R&D and Licensing
-
The scope influences freedom-to-operate; broad claims may limit competitors’ activities.
-
Narrow claims restrict generic entry but might be easier to defend against invalidity.
-
Licensing opportunities depend on whether the patent covers key formulations or indications.
Conclusion
Patent AU2009282474 primarily protects specific pharmaceutical compositions or methods related to a drug candidate. Its claims define a range of claims from broad compositions to specific formulation details. The patent landscape includes related filings globally, with overlapping rights and potential for litigation or licensing.
Key Takeaways
- The patent covers specific formulations and methods related to a pharmaceutical compound, primarily in Australia.
- The scope is delineated through a mix of broad and narrow claims, focusing on compositions and therapeutic uses.
- Its position within the global patent landscape influences potential commercialization, licensing, and patent litigation strategies.
- The patent’s validity depends on its differentiation from prior art, and ongoing prosecution or challenges may modify its scope.
FAQs
Q1: How does the scope of AU2009282474 compare to similar patents in other jurisdictions?
It may have broader claims in Australia but could be narrower or broader depending on filings in other countries. Patent families often attempt to optimize territorial coverage.
Q2: Are the claims covering method of treatment or only composition?
The claims likely include both composition and method-of-use claims, which can influence enforcement strategies.
Q3: What challenges could face this patent regarding validity?
Challenges could arise over lack of novelty, obviousness based on existing prior art, or insufficient inventive step.
Q4: Can this patent be licensed to generic manufacturers?
Licensing depends on the scope of claims, market exclusivity, and whether the patent is enforceable or challenged.
Q5: How long is the patent protection expected to last?
Assuming a filing date around 2009, the patent's life extends to approximately 2029, subject to maintenance fee payment.
References
- Australian Patent Office. (2009). Patent AU2009282474.
- World Intellectual Property Organization. (2022). Patent Landscape Reports.
- European Patent Office. (2022). Patent Search Databases.
- Patent Scope. (2022). WIPO Patent Database.
- Google Patents. (2022). Patent AU2009282474.
